ADCT

ADCT

USD

ADC Therapeutics SA Common Shares

$4.040-0.050 (-1.222%)

Precio en Tiempo Real

Healthcare
Biotecnología
Suiza

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$4.090

Máximo

$4.140

Mínimo

$3.630

Volumen

1.21M

Fundamentos de la Empresa

Capitalización de Mercado

454.5M

Industria

Biotecnología

País

Switzerland

Estadísticas de Negociación

Volumen Promedio

0.89M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $1.05Actual $4.040Máximo $4.8

Noticias Relacionadas

PR Newswire

ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today reported...

Ver más
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
PR Newswire

ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that...

Ver más
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
PR Newswire

ADC Therapeutics to Present at November Investor Conferences

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced...

Ver más
ADC Therapeutics to Present at November Investor Conferences

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.